YC Companies/Winter 2022/WhiteLab Genomics
WhiteLab Genomics logo

WhiteLab Genomics

Unleashing the potential of DNA and RNA based therapies using AI

Winter 2022Healthcare / Healthcare -> Drug Discovery and DeliveryParis, Île-de-France, France; Boston, MA, USA40 employees
Artificial Intelligence
Gene Therapy
Cell Therapy
Genomics

About

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

Founders (2)

David Delbourgo
Founder
Julien Cottineau
Founder

Details

Status
Active
Stage
Growth
Team Size
40
Regions
France, United States of America, Europe, America / Canada, Remote, Partly Remote
WhiteLab Genomics | YC Companies | GPAgent